Long‐standing remission after 25‐OH D3 treatment in a case of chronic myelomonocytic leukaemia

Leonardo Mellibovsky, Adolfo Díez, Jaume Aubia, Xavier Nogues, Encarna Pérez‐Vila, Sergi Serrano, Robert R. Recker

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

12 Cites (Scopus)

Resum

Summary This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25‐OH vitamin D3. No side‐effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This ‘differentiation therapy’ might be considered as a possible alternative in the management of this disease. Copyright © 1993, Wiley Blackwell. All rights reserved
Idioma originalAnglès
Pàgines (de-a)811-812
RevistaBritish Journal of Haematology
Volum85
Número4
DOIs
Estat de la publicacióPublicada - 1 de gen. 1993

Fingerprint

Navegar pels temes de recerca de 'Long‐standing remission after 25‐OH D3 treatment in a case of chronic myelomonocytic leukaemia'. Junts formen un fingerprint únic.

Com citar-ho